| 121/237 | US=58 / Câncer Le XF, Bast Junior RC. p27Kip1 as a biomark and target for treatment of cancer. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 215-33. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. P27KIP1; CICLO CELULAR; SUPRESSOR DE TUMOR; TERAPIA ALVO; TRASTUZUMAB |
| 122/237 | US=58 / Câncer Pevarello P, Bischoff JR, Mercurio C. Targeting cyclin-dependent kinases with small molecular inhibitors. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 235-44. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. CICLINA DEPENDENTE DE QUINASE; INIBIDOR DE MOLECULA PEQUENA; SELETIVIDADE; DE MULTI-ALVO; ENSAIOS CLINICOS |
| 123/237 | US=8 / Dermatologia Legat FJ, Armstrong CA, Scholzen T, Olerud JE, Bunnett NW, Luger TA, Ansel JC. Neurobiology of the skin. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editores. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 230-6. ISBN 978-0-07138076-0. NEUROBIOLOGIA DA PELE; INFLAMACAO NEUROGENICA; SISTEMA SENSORIAL NERVOSO CUTANEO; NEUROPEPTIDEO ALVO; INFLAMACAO DA PELE |
| 124/237 | US=80 / Biol/Mol Alaoui-Jamali MA, Pinto D. Proteomic profiling of tyrosine kinases as pharmacological endpoints for targeted cancer therapy. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 59-77. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. TIROSINA-QUINASES PROTEICAS; CANCER; TERAPIA-ALVO; PROTEOMICA |
| 125/237 | US=80 / Biol/Mol Li D, Hackett J, Chan M, Pennello G, Gutman S. Regulatory issues in the co-development of oncology drugs and proteomic tests: an overview. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 237-58. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. |
| 126/237 | US=84 / Biol/Mol Fonsatti E, Maio M. TGF-B superfamily members in normal and tumor biology: endoglin (CD105): a strong candidate for immunologic targeting of tumor neovasculature in human malignancies. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 395-410. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. ENDOGLINA; CD105; ANGIOGENESE; CARCINOGENESE; CELULAS ENDOTELIAIS; VASCULAR ALVO |
| 127/237 | US=84-A / Biol/Mol Micke P, Moustakas A, Ohshima M, Kappert K. Transformig growth factor-B in developing and advanced cancers: cancer-associated fibroblasts and the role of TGF-B. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 417-41. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. ASSOCIADAS CANCER FIBROBLASTOS; ESTROMA; ASSOCIADAS CANCER FIBROBLASTOS; TUMOR DO ESTROMA INTERACCAO; MIOFIBROBLASTOS; TERAPIA-ALVO; TGFB-1; MICROARRAY; EXPRESSAO DO GENE; CANCER |
| 128/237 | US=86 / Biol/Mol Tan TT, White E. Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 81-104. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. SEGMENTACAO TERAPEUTICO; VIAS DE MORTE EM CANCER; MECANISMOS; MORTE CELULAR; CELULAS CANCERIGENAS; APOPTOSE; QUIMIOTERAPIA; TERAPIA ALVO; FAMILIA BCL-2; RECEPTORES DE MORTE; INIBIDORES DO SINAL DE TRANSDUCAO |
| 129/237 | US=1 / Quimioterapia Gaddis JS, Gullatte MM. Pharmacologic principles of chemotherapy. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 19-37. ISBN 978-1-890504-68-7. FARMACOLOGICOS DE QUIMIOTERAPIA; CICLO CELULAR DE RESPOSTA QUIMIOTERAPIA; AGENTES ANTINEOPLASICOS; AGENTES ALQUILANTES; TOXICIDADE DOS AGENTES ALQUILANTES; ANTIMETABOLITOS; TOXICIDADE ANTIMETABOLITO; ANTIBIOTICOS ANTITUMORAIS; FACTORES DE CRESCIMENTO HEMATOPOIETICOS; HORMONIOS; ALCALOIDES DE PLANTAS; TERAPIAS-ALVO MOLECULAR; ANTICORPOS MONOCLONAIS |
| 130/237 | US=1 / Quimioterapia Esper P. Targeted therapy. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 57-75. ISBN 978-1-890504-68-7. TERAPIA-ALVO; TERAPIA DO CANCER; HISTORIA TERAPIAS-ALVO; EVOLUCAO DE TERAPIAS-ALVO; ALVO RECEPTORES DA SUPERFICIE CELULAR; PAPEL DO ENFERMEIRO DE ONCOLOGIA EM TERAPIA-ALVO; PACIENTE E EDUCACAO FAMILIAR |
| 131/237 | US=111 / Câncer Thomson JM, Hammond SM. Micro-RNAs as oncogenes and tumour suppressors. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 89-98. ISBN 978-0-470-01852-1. CANCER; MICRO-RNAS; ONCOGENE; SUPRESSORES DE TUMOR; BIOGENESE; MICRO-RNA ALVO; FUNCAO BIOLOGICA DOS MICRO-RNAS |
| 132/237 | US=111-A / Câncer Wang P, Li S. Genetic models: a powerful technology for the study of cancer. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 905-17. ISBN 978-0-470-01852-1. CANCER; PESQUISA DO CANCER; MODELOS GENETICOS; TECNOLOGIA; EXPERIMENTOS; GENE ALVO; APRISIONAMENTO DE GENE |
| 133/237 | US=16 / Urologia Chung LWK, Huang WC, Sung SY, Wu D, Odero-Marah V, Zhau HE. Biology and imaging: cancer-host interactions. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 73-86. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. BIOLOGIA; IMAGEM; CANCER DE PROSTATA; METASTASE OSSEA; SINALIZACAO CELULAR; MODULACAO EPIGENETICA DA EXPRESSAO GENICA; TRANSICAO EPITELIAL/MESENQUIMAL; MATRIZES EXTRACELULARES; FATORES DE CRESCIMENTO; INFLAMACAO; ALVO MOLECULAR; TERAPIA; OSTEOMIMICRY; CELULAS-TRONCO; INTERACAO TUMOR ESTROMAL |
| 134/237 | US=16 / Urologia Gao X, Xing Y, Chung LWK, nie S. Biology and imaging: quantum doto nanotechnology for prostate cancer research. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 231-44. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. BIOLOGIA; IMAGEM; NANOTECNOLOGIA; PONTO QUANTICO; CANCER DE PROSTATA; PESQUISA; FLUORESCENCIA; IMAGEM MOLECULAR; TUMOR ALVO |
| 135/237 | US=22 / Radioterapia Khan FM. Introduction: process, equipment, and personnel. In: ___. Treatment planning in radiation oncology. 2ª ed. Philadelphia: Lippincott Williams & Wilkins, 2007. p. 1-9. ISBN 0-7817-8541-3. RADIOTERAPIA; PROCESSO DE PLANEJAMENTO DO TRATAMENTO; AVALIACAO DO VOLUME ALVO; VOLUME DE TRATAMENTO; DISTRIBUICAO DE ISODOSE; CAMPOS DE TRATAMENTO; CAMPO DE FORMACAO; MODULACAO DE INTENSIDADE; BRAQUITERAPIA; EQUIPAMENTOS; UNIDADES EXTERNAS FEIXE; EQUIPAMENTO DE BRAQUITERAPIA; EQUIPAMENTOS DE IMAGEM; SISTEMAS DE IMAGEM; COMPUTADORES; RECURSOS HUMANOS |
| 136/237 | US=21 / Neurologia Kanner AA. Contemporary investigational treatments: convection-enhanced delivery. In: Barnett GH. High-grade gliomas: diagnosis and treatment. New Jersey: Humana Press, 2007. p. 303-14. (Current Clinical Oncology) ISBN 978-1-58829-511-8. GLIOMA DE ALTO GRAU. TERAPIA; ENTREGA INTENSIFICADA POR CONVECCAO; NEOPLASIA CEREBRAL; TERAPIA ALVO; ENSAIOS CLINICOS |
| 137/237 | US=21 / Neurologia Vogelbaum M, Thomas T. Contemporary investigational treatments: small molecule agents. In: Barnett GH. High-grade gliomas: diagnosis and treatment. New Jersey: Humana Press, 2007. p. 337-56. (Current Clinical Oncology) ISBN 978-1-58829-511-8. GLIOMA DE ALTO GRAU. TERAPIA; AGENTES MOLECULARES; INIBIDORES DE GLIOMA; FATORES DE CRESCIMENTO; DROGAS DE MOLECULAS PEQUENAS; TERAPIA-ALVO; INIBIDORES DE QUINASE DE TIROSINA |
| 138/237 | US=35 / Câncer Sausville EA. Molecular therapeutics of AML: selected targeted approaches: emerging therapeutics for AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 231-46. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; EMERGENCIAS TERAPEUTICAS; NOVOS AGENTES; TERAPIA ALVO; VACINA; SINALIZACAO VEGF; ADAFOSTINA; TRITERPENOIDES |
| 139/237 | US=46 / Câncer Reiter Y, Lev A. Immunotoxins and recombinant immunotoxins in cancer therapy. In: Meyers RA. Cancer: from mechanisms to therapeutic approaches. New Jersey: Wiley-Blackwell, 2007. p. 409-41. ISBN 978-3-527-31768-4. IMUNOTOXINAS; IMUNOTOXINAS RECOMBINANTES EM TERAPIA DO CANCER; TERAPIA DO CANCER; IMMUNOTOXINS; ANTICORPOS RECOMBINANTES; TERAPIA-ALVO |
| 140/237 | US=58 / Biol/Mol Guimaraes ASR, Weissleder R. Magnetic resonance probes for tumor imaging. In: Shields AF, Price P. In vivo imaging of cancer therapy. New Jersey: Humana Press, 2007. p. 259-80. (Cancer Drug Discovery and Development) ISBN 978-1-58829-633-7. SONDAS PARA IMAGIOLOGIA DE RESSONANCIA MAGNETICA TUMOR; AGENTES GADOLINIO; NANOPARTICULA MAGNETICA; ANGIOGENESE IMAGEM; NANOPARTICULA MAGNETICA COMO AGENTES LINFOTROPICOS; RASTREAMENTO DE PILHA DE IMAGENS; ALVO AS CELULAS TUMORAIS; NANO-SENSORES MAGNETICOS |